Exclusive

Publication

Byline

BioNet and Bio Farma sign strategic MoU to expand TdaP vaccine access in ASEAN

Singapore, June 4 -- BioNet, a Franco-Thai vaccine biotech group, and PT Bio Farma (Persero),Indonesia'sstate-owned vaccine manufacturer, have signed a Memorandum of Understanding (MoU) to collaborate... Read More


Australia boosts development of revolutionary saliva test for liver fibrosis detection

Singapore, June 4 -- A ground-breaking test to diagnose liver fibrosis has received a boost after lead researcher, Professor Chamindie Punyadeera, was selected on to the prestigious LuminaX HealthTech... Read More


Japanese startup ThinkCyte unveils cloud-based platform for AI-driven cell morphology data analysis

Singapore, June 4 -- ThinkCyte, a Japan-based life science company pioneering advanced artificial intelligence (AI)-powered cell analysis and sorting technologies, has announced the pre-commercial lau... Read More


Milestone partnership highlighting Korea's expanding influence in global biotech innovation

Singapore, June 3 -- MarkHerz Inc., a South Korea-based biotechnology startup specialising in AAV-based gene therapies targeting cardiovascular and metabolic diseases, has signed a Memorandum of Under... Read More


Thailand inks MoUs to strengthen medical ties with Bahrain and Indonesia

Singapore, June 3 -- The Faculty of Medicine Ramathibodi Hospital, Mahidol University, Ramathibodi (Thailand) and the Royal College of Surgeons in Ireland - Medical University of Bahrain (RCSI Bahrain... Read More


Taiwan's KMUH inks MoU with AbbVie to accelerate global clinical trials and advance patient-centered innovation

Singapore, June 3 -- To accelerate clinical trial activation and execution, enhance research quality, and strengthen international competitiveness, Taiwan's Kaohsiung Medical University Chung-Ho Memor... Read More


Japan's Fujifilm rebrands Life Sciences companies to represent board spectrum portfolio

Singapore, June 3 -- Japan-headquartered Fujifilm Corporation's Life Sciences Group companies, a portfolio of businesses offering products, services and comprehensive solutions that span all stages of... Read More


Eisai launches Pariet(R) S, first proton pump inhibitor RX-to-OTC in Japan

Singapore, June 2 -- Eisai Co. has announced the launch of Pariet(R) S"(pharmaceutical requiring guidance), which is highly effective in alleviating severe heartburn and stomach pain caused by gastric... Read More


Sanofi buys Blueprint Medicines for $9.1 B, expanding portfolio in rare immunological disease

Singapore, June 2 -- French pharmaceutical company Sanofi and Blueprint Medicines Corporation, a US-based, publicly traded biopharmaceutical company specialising in systemic mastocytosis (SM), a rare ... Read More


PlasmidFactory: Pioneering Minicircle DNA for Safer and More Efficient Gene Therapies

Singapore, June 1 -- As the field shifts toward safer and more efficient gene delivery methods, PlasmidFactory's proprietary technology for producing non-synthetic minicircle DNA is gaining rapid atte... Read More